ArticleEuropean journal of midwifery2024
Women's bodily experience of antenatal breastmilk expression from 34 weeks of gestation: Qualitative results from the Express-MOM study.
Article in European journal of midwifery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05516199 (Antenatal Breastmilk Expression From Week 34 of Gestation Safety in Pregnancy and Benefits for the Newborn Infant), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Antenatal Breastmilk Expression From Week 34 of Gestation Safety in Pregnancy and Benefits for the Newborn Infant: A Pilot Randomized Study
Who cites it
2 citing papers in PubMed.
- Information and practices of antenatal colostrum expression: a cross-sectional study of pregnant women in Norway.BMC pregnancy and childbirth · 2026Article
- Maternal satisfaction on breastfeeding among paediatric outpatient mothers.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreastfeeding establishment can be challenging due to several factors including women's emotional and physical perception of breastfeeding. This study examines the bodily experiences of healthy women performing antenatal breastmilk expression (aBME) from gestational week 34 until term and whether aBME can support women during breastfeeding establishment.
methodsA qualitative phenological-hermeneutic approach was applied. In-depth semi-structured interviews were conducted from December 2022 to March 2023, and women were recruited from the Express-MOM Study, which examined aBME before term. Interviews were conducted 2-4 weeks after birth. Questions concerned body image, bodily experience of aBME, and whether aBME supported their confidence during breastfeeding establishment. Interviews were audio recorded, verbatim transcribed, coded by the first and last author, and subjected to thematic analysis.
resultsSeven women participated in the interviews. Three themes were identified: 1) A desire to be prepared, which identified how women had a deep-felt wish to provide their infants with their milk; 2) Bodily confident, which covered how women trusted their body when expressing milk through aBME, and how this increased their confidence in breastfeeding; and 3) Being confident in the storm, which addressed how knowledge about women's own body obtained from aBME was valuable in the vulnerable breastfeeding establishment.
conclusionsaBME from 34 weeks of gestation can contribute to women feeling more bodily confident and prepared for breastfeeding establishment. This study provides a basis for future research on aBME in women at risk of breastfeeding difficulties (e.g. preterm delivery) to identify if aBME can increase breastfeeding confidence and also breastfeeding initiation and rates. CLINICAL
trial registrationThe study is registered on the official website of ClinicalTrials.gov. IDENTIFIER: ID NCT05516199.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.